Long-term central venous catheters: Issues for care

Seminars in Oncology Nursing

Volumn 8, Issue 2, 1992, Pages 133-147

  Wickham, Rita ^a   Purl, Sandra ^a   Welker, Diane ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b HURLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL VENOUS CATHETERIZATION; CONTRAST MEDIUM EXTRAVASATION; EQUIPMENT; HUMAN; INDWELLING CATHETER; INFECTION; LONG TERM CARE; METHODOLOGY; NURSING; REVIEW; RISK FACTOR; STANDARD; THROMBOPHLEBITIS;

CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; EQUIPMENT FAILURE; EVALUATION STUDIES; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMAN; INFECTION; LONG-TERM CARE; ONCOLOGIC NURSING; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; THROMBOPHLEBITIS;

EID: 0026856085     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/0749-2081(92)90029-3     Document Type: Article

References (123)

1. Central venous catheter complications
2. Advanced central venous access. Selection, catheters, devices, and nursing management
3. A trial with a new peripherally implanted vascular access device
4. PICC lines: The latest home care challenge
5. Venous access devices: An overview
6. Prolonged venous access for chemotherapy by means of the Hickman catheter
7. Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization
8. Catheter-related thrombosis.
9. Hickman catheter complications in marrow transplant recipients
10. The malfunctioning silastic catheter—radiologic assessment and treatment
11. Thrombosis after central venous cannulation
12. Evaluation of the elastic behaviour of central venous PVC, polyurethane and silicone catheters
13. Autopsy findings after prolonged catheterization of the right atrium for chemotherapy in acute leukemia
14. Evaluation and use of advanced IV technology. Part 1: Central venous access devices
15. Changing concepts of deep venous thrombosis of the upper extremity—report of a series and review of the literature
16. Tunneled catheter thrombosis: Factors related to incidence
17. The prethrombotic state in cancer
18. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis
19. Thrombosis: The major Hickman catheter complication in patients with solid tumor
20. Catheter tip position in central vein thrombosis
21. Unusual case of central vein thrombosis and sepsis
22. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer
23. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy
24. Central venous thrombosis related to the silastic Hickman-Broviac catheter in an oncologic population
25. Fibrinolytic agents in the treatment of thrombotic disorders
26. Complications and management of implanted venous access catheters
27. Superior vena caval obstruction in patients with gut failure receiving home parenteral nutrition
28. Hickman catheter-induced thoracic vein thrombosis
29. Catheter-related septic central venous thrombosis-current therapeutic options
30. The diagnosis and treatment of thrombosis in the cancer patient
31. Prophylaxis against central venous thrombosis with low-dose warfarin
32. Very low doses of warfarin can prevent thrombosis in central venous catheters
33. Subclavian vein thrombosis: A continuing challenge
34. Successful fibrinolytic therapy for superior vena cava thrombosis secondary to long-term total parenteral nutrition
35. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients
36. How to give thrombolytic therapy safely
37. The use of thrombolytic agents: Choice of patient, drug administration, laboratory monitoring
38. Anticoagulation and thrombolytic therapy. Practical considerations
39. Hickman catheter infections in patients with malignancies
40. Central venous catheter infections
41. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients
42. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
43. Management of the febrile neutropenic patient with cancer
44. Infectious complications of indwelling long-term central venous catheters
45. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters
46. Coagulase-negative staphylococcal adherence and persistence
47. Venous access in the cancer patient
48. Management of septic complications associated with silastic catheters in childhood malignancy
49. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition
50. Sepsis from triple vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients
51. Assessment of catheter-associated infection risk with the Hickman right atrial catheter
52. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: A randomized trial in 100 patients with solid tumors
53. Infection rates of Broviac-Hickman catheters and implantable venous devices
54. Prolonged bacteremia with catheter-related central venous thrombosis
55. Treatment of an infected silicone right atrial catheter with combined fibrinolytic and antibiotic therapy: Case report and review of the literature
56. Management of Hickman catheter sepsis
57. Fatal tricuspid valve obstruction due to a large infected thrombus attached to a Hickman catheter
58. Hickman-Broviac catheters. Indications and results
59. Hickman-Broviac catheter use in cancer patients
60. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome
61. Indwelling central venous catheter infections in patients with acquired immune deficiency syndrome
62. Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition
63. Total parenteral nutrition catheter sepsis: Impact of the team approach
64. Perspective on the management of catheter-related infections in cancer patients
65. Management of cutaneous reactions and mechanical complications of central venous access devices in pediatric patients with cancer: Algorithms for decision making
66. Indwelling central venous catheter-related infections and two different procedures of catheter care
67. Nursing management of infusion catheters
68. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures
69. Central venous septic thrombophlebitis—the role of medical therapy
70. A prospective study of complications in Hickman right-atrial catheters in marrow transplant patients
71. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms
72. In situ management of confirmed central venous catheter-related bacteremia
73. Quantitative blood cultures in the evaluation of septicemia in children with Broviac catheters
74. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci
75. Complications from long-term venous catheters in hematologic patients with special reference to infection
76. Results from use of 826 vascular access devices in cancer patients
77. An attachable silver-impregnated cuff for prevention of infection with central venous catheters A prospective randomized multicenter trial
78. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection
79. Catheter sepsis: The clue is the hub
80. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters
81. Infection rates in central venous catheter dressings
82. Dressing changes by specialized personnel reduce infection rates in patients receiving central venous parenteral nutrition
83. Calcium phosphate crystal occlusion of central venous catheters used for total parenteral nutrition in infants and children: Prevention and treatment
84. Treatment of central venous catheter occlusions with hydrochloric acid
85. The use of urokinase to restore the patency of occluded central venous catheters
86. Continuous infusion of low-dose urokinase in the treatment of central venous catheter thrombosis in infants and children
87. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters
88. Use of hydrochloric acid to clear obstructed central venous catheters
89. Ethanol lock in the management of catheter occlusion
90. Drug extravasation as a complication of venous access ports
91. Extravasation. A serious complication of the split-sheath introducer technique for venous access
92. Extravasation of doxorubicin from a Hickman catheter: A case presentation
93. Intrathoracic extravasation of sclerosing agents associated with central venous catheters
94. Extravasation from venous access devices
95. Drug extravasation and the Port-a-Cath system
96. Needle dislodgement from implanted venous access devices: Inpatient and outpatient experiences
97. Implantable central venous access systems
98. Experience with subcutaneous infusion ports in three hundred patients
99. Experience with the portacath
100. Drug extravasation in cancer chemotherapy
101. In situ breakage of a totally implanted venous access system
102. the “pinch-off sign”: A warning of impending problems with permanent subclavian catheters
103. Catheter fracture and embolization in a totally implanted venous access catheter
104. Spontaneous intravenou catheter fracture and embolization from an implanted venous access port and analysis by scanning electron microscopy
105. Hickman catheter separation
106. Etiology and treatment of chemotherapeutic agent extravasation injuries: A review
107. Central venous catheter malposition presenting as chest pain
108. Hickman catheter tip displacement
109. Recurrent secondary displacement of long-term indwelling silastic atrial catheters
110. Coughing and central venous catheter dislodgement
111. Impending catheter perforation of superior vena cava: Radiographic recognition
112. Fatal pericardial tamponade complicating total parenteral nutrition via a silastic central vein catheter
113. Implantable venous access device: Use in patients with advanced head and neck cancer
114. Intrapericardial infusion of 5-fluorouracil. An unusual complication of a Hickman catheter
115. Significance of a curled central venous catheter tip
116. Central venous catheter vascular erosions. Diagnosis and clinical course
117. Complications associated with central venous catheters. A survey
118. Quality assurance monitoring through use of a vascular access device flowsheet
119. Multidisciplinary management of vascular access devices